the response to sodium mtroprusside was not affected (maximum percent increase m forearm blood flow 480 2239 3%; P=NS) These results suggest a protective role of endogenous estrogen on endothehum-dependent vasochlation m the forearm vascular bed of normotensive women (Hypertension. 1997; 29[part 2]:268-273.) Key Words l endothehum l acetylchohne l estrogen l sodium mtroprusside E pldemlologlcal mvestigatlons have demonstrated that menopause is associated with an increased risk of CVD, showing that sex differences m the incidence and seventy of CVD are no longer found after menopause 1.2 Moreover, women who undergo early menopause, either surgically or naturally, are at increased risk of developing coronary heart disease m comparison with premenopausal women of the same age.3 Sex-hormone deficiency, independently of aging, seems therefore to be responsible for the enhanced nsk of CVD, as also suggested by the favorable effects of ERT on cardiovascular morbldlty and mortahty 43 Although there 1s mcreasmg evidence of the protection afforded by ERT agamst CVD, the underlying mechanisms remam not fully explamed Estrogens are beheved to play a protective role on the cardiovascular system mainly by a beneficial action on lipid profile, especially by favorably affecting plasma concentration of lipoproteins, by mterfenng with cholesterol deposition in the arterial wall and by preserving LDL from oxldatlon 6-8 Besides these hpld-mediated effects, recent data point to a direct vascular action of estrogens, which have been demonstrated to improve vascular reactivity, possibly by calFromIChn~caMedica(SP,AV,LG,GB,ST,AS)andthe Department of Obstetrics and Gynaecology (M L , A R G ), Umversity of Plsa, and the Department of Obstetrics and Gynaecology, Umversity of Modena (F P ), Italy
Correspondence to Stefanla Pinto, MD, I Chtuca Me&a, Umverslty of Plsa, Via Roma, 67, 56100 Plsa, Italy 0 1997 American Heart Assoclatlon, Inc cmm channel blockmg-like action9 and/or by mterplaying with endothelial vasoactlve factors. 10,1I It 1s now well documented that the endothelmm plays a pnmary role m the modulation of vascular tone through the production of different factors, of which the most Important 1s NO, a labde substance released by endothehal cells dunng the catabolism of L-argmme mto cltrullme through the activity of the NO synthase enzyme. 12 There 1s clmlcal and expenmental evidence suggesting that exogenous estrogens affect endothehum-dependent vasodilation of penpheral and coronary arteries m estrogendeficient animals 13-15 and m menopausal women. 16-19 Acute estrogen admmlstratlon has been reported to improve vasoreactlvlty m healthy postmenopausal women at dosages achieving serum concentrations typical of the mldcycle of reproductive-age women 20 Moreover, a beneficial effect of acute estrogen admmlstratlon on myocardlal lschemla has been found m postmenopausal women with anglographlcally proven coronary artery dlsease.21 On the other hand, endogenous estrogen seems to play a protective role on endothehal function since m normotenstve women the age-related lmpalrment of endothelium-dependent vasodllation occurs later m comparison with men, appearmg only around the time of menopause **v*~ Moreover, a protective effect of endogenous estrogen has also been shown m essential hypertensive women. 22
Therefore, postmenopause IS characterized by the loss of an estrogen-dependent mechanism protecting vascular function However, no reports are yet available on the effect of acute endogenous estrogen deprivation on vaby guest on February 23, 2013 http://hyper.ahajournals.org/ Downloaded from I Selected Abbreviations and Acronyms CVD = cardiovascular disease ERT = estrogen replacement therapy FBF = forearm blood flow LDL = low-density lipoprotein NO = nitric oxide NS = not significant somotor response m women of reproductive age Thus, tlus study was planned to assess the effect of surgical menopause on endothelium-dependent vasodllatlon m fertile women who underwent bilateral ovarlectomy for uterine leiomyoma Subjects Methods A group of 10 women, aged 47 4&l 6 (range 45 to 51) years, with symptomatic uterme lelomyoma associated with menorrhagia (n=8), pelvic pain (n=l), or rapid increase. m Size (n= 1) was enrolled m the study All patients had regular menstrual cycles, no i-ustory of hypertension, CVD, dyshpldemla, diabetes melhtus, obesity, or any other major systemic illness As control subjects, we enrolled 10 healthy women, aged 48 252 9 (range 43 to 50) years, who were matched for hemodynatmc and humoral charactenstlcs (Table 1) No pattents had received hormone treatment or had had a pregnancy for at least 6 months before the study All subjects had been free from any drugs for at least 4 weeks Only 2 were mild smokers (less than 5 cigarettes a day)
In accordance with mstltutlonal gmdelmes, all patients were aware of the mvestlgatlonal nature of the study and gave written consent to it
Experimental Procedure
All studies were performed at 8 00 AM, after overnight fasting, with the subjects lying supme m a quiet nr-conditioned room (22°C to 24°C) A polyethylene cannula (21 gauge, Abbot) was inserted mto the braclual artery under local anesthesia (2% hdocame) The cannula was connected through stopcocks to a pressure transducer (model MS20, Electromechcs) for the determmatlon of systemic mean arterial blood pressure (one third pulse pressure plus diastolic pressure) and heart rate (model VSMl, Physiocontrol), and for mtra-arterial mfusions by a Harvard infusion pump (series 944A, Eahng) FBF was measured m both forearms (expenmental and contralateral) by stram-gauge venous plethysmography (LOOSCO, GL LOOS) 24 The clrculation to the hand was excluded 1 minute before each measurement of FBF by mflatmg a pechatnc cuff around the wrist, at suprasystolic blood pressure Earher work has deterrnmed the sensmvlty and the reproducibility of the method 25 Forearm volume was measured by the water-displacement method, and infusion rates of drugs were normahzed to 100 mL of tissue by altering the drug concentration In the solvent, while the speed of infusion was not modified The drugs used were infused through separate ports via three-way stopcocks at concentrations that had no systemic effects Experimental Design Endothehum-dependent vasodllations were estimated by performing a dose-response curve to mtra-arterial acetylchohne (cumulative increase of the infusion rates 0 15, 0 45, 1 5, 4 5, 15 pg/lOO mL forearm tissue per minute, for 5 minutes at each dose),*627 while endothehum-independent vasochlatlons were assessed with a dose-response curve to mtra-arterial sodium mtroprusside** (cumulative increase by 1,2, and 4 pg/lOO mL forearm tissue per mmute, for 5 minutes each). These rates were selected to induce vasochlation comparable to that obtained with acetylcholine The sequence of mfuslon of the two drugs was randomlzed and 45 minutes of recovery were allowed between the two experimental steps
Forearm study was performed during the follicular phase m both control sublects and patients Patients repeated the study within 1 month after ovariectomy (2422 days) Finally, 6 of 10 patients were studied again 3 months after ERT (transdermal estrachol, TTS 50, 50 pg/24 h) Data Analysis Data were analyzed m terms of changes m FBF Since mean arterial blood pressure did not significantly change during the study, increments m FBF were taken as evidence of local vasodilation Results were expressed as mean+SD m text and as mean+SEM m the figures and tables Data were analyzed statistically by the t test for paired or unpaired observations and by ANOVA for repeated measures Scheffb's test was applied for multiple comparison testing A value of P< 05 was considered to be stahstically significant Drugs Acetylchohne HCl (Farmlgea SpA) and sodrum mtroprusside (Malesci) were obtained from commercially available sources and diluted freshly to the desired concentration by addmg normal salme Sodium mtroprusslde was chssolved m glucosate solution and protected from light by an alummum fml
Results
The systermc demographic, hemodynarmc, and humoral charactenstlcs for control subjects and patients are summanzed in Table 1 . There was no significant difference m baselme values between control SubJects and patients. Moreover, after ovanectomy and ERT, there was no statistically slgmflcant modification m basal parameters compared with values found before surgery. It 1s worth noting that no statistical difference m blood pressure values or lipid and glucose profile was observed when basal conditions, ovariectomy, and ERT were compared. Moreover, plasma estradiol values did not differ between control subJects and patients (76 5?34 3 and 71.6?31 3 pg/mL, respectively) and as expected fell to undetectable levels after ovanectomy. Finally, during ERT, plasma estrogen levels were 48 62 13.9 pg/nL.
Response to Intrabrachial Acetylcholine and Sodium Nitroprusside
Vasodllatlon to acetylcholme was not significantly dlfferent between control SubJects (FBF rose from 3 6+-O 4 to a maximum of 25 1+4 9 mL/lOO mL forearm tissue per minute with the highest dose) and patients before surgery (FBF rose from 3 520 5 to a maximum of 23.454 5 mL/ 100 mL forearm tissue per mmute with the highest dose) (Fig 1) The vasodllatmg effect of the endothelmm independent vasodllator sodium nitroprusslde was also similar in control subjects and patients (FBF rose from 3.420 4 to a maximum of 22.323 6 mWlO0 mL forearm tissue per minute with the highest dose and from 3 420.4 to a maximum of 21.3 k3 1 mL/lOO mL forearm tissue per minute, respectively, NS) (Fig 1) After ovarlectomy the response to acetylcholme was significantly (P< 001) blunted compared with premterventlon results (maximum to acetylcholme from 3 4t (Fig 2) while the vasodllatlon to sodmm mtroprusslde was not altered (maximum to sodium mtroprusslde from 3 520.4 to 19 423.7 mL/lOO mL forearm tissue per mmute) (Fig 2) Finally, the effect of ERT was evaluated m a subgroup of our study population (6 of 10) ( Table 2 ). In these subjects, vasodllatlon to acetylcholme, which before ovanectomy was similar to values observed in control subjects (maximum to acetylcholme from 3.620.4 to 25 823 9 mL/lOO mL forearm tissue per minute), was found to be slgmficantly blunted after surgery (maximum to acetylcholine from 3 3+-O 4 to 14 722 4 mL/lOO mL forearm tissue per minute, P< 0.5 versus preovarlectomy) (Fig 3) However, after 3 months of ERT the vasoddatmg effect of acetylcholme was significantly (P< 02) increased compared with postovarlectomy results (maximum to acetylcholme from 3.5-+0 5 to 25 5+-3 1 mL/lOO mL forearm tissue per minute) (Fig 3) and it 1s worth noting that tt was no longer stattstmally different compared wtth preovariectomy values (Fig 3) In contrast, m the same subgroup of patients, the response to sodmm mtroprusside (maximum to sodium mtroprusside from 3 450 4 to 22.423.1 mWlO0 mL forearm tissue per minute) observed before ovariectomy was unchanged either after surgery (maximum to sodmm mtroprusside from 3.1 t 0 4 to 19 2?2 8 mL/lOO mL forearm tissue per minute, NS versus preovartectomy) or ERT (maximum to sodium mtroprussrde* from 3.4504 to 23 623 2 mUlO mL forearm tissue per minute; NS versus preovartectomy or postovartectomy) (Fig 3) 
Discussion
The present study was designed to test the effect of acute endogenous estrogen deprivation on endothelmmdependent vasodilation m women m reproductive age Therefore, m a group of female patients who underwent bilateral ovariectomy for uterine letomyoma, we evaluated the forearm vascular response to acetylchohne and sodium mtroprusstde, an endothelmm-dependent and -Independent vasodilator, respectively. As control subjects we selected healthy women well matched with the study group population for demographic and clmical parameters Particular attention was paid to risk factors tmpairing endothelial function such as age, blood pressure, phase of the menstrual cycle, lipid and glucose profile, and smokmg htstory In the two study populatrons, the response to acetylcholme and sodium mtroprusstde was stmtlar, indicating preserved endothelmm-dependent vasodilation m patients with letomyoma. In contrast, after bilateral ovariectomy, the response to acetylcholine was found to be reduced compared with premtervention results. Smce the vasodilatmg effect of sodmm mtroprusside remained unchanged, this finding suggests that acute estrogen deprivation leads to selective impairment of endothehum-dependent vasodilatton. Thus possibihty IS further confirmed by results obtained after ERT. Thus, m a subgroup of ovariectomized patients (6 of lo), ERT stgmficantly increased the response to acetylcholme compared with that observed after ovariectomy Moreover, the effect of acetylcholine after ERT was no longer different compared with the response observed m basal condttrons (before ovariectomy) or m the control group. Since again the vasodilatmg effect of sodmm mtroprusside did not change, these findings not only indicate that ERT restores endothelmm-dependent vasodtlation m short term estrogen deprived women but also further confirm the positive effect of estrogen on endothelial function
The most likely explanation for the beneficial effect of estrogen on endothelium-dependent vasodtlatron, as observed m our experimental condttions, is represented by a direct effect of the hormone on endothehal function. Although the exact mechanism by which endogenous estrogen protects the endothehum cannot be determined from the present study, experimental evidence mdicates that admmtstration of estrogen upregulates the transcrtpnon of NO synthase, the key enzyme regulating NO production.
In addttton, a further possible explanation is suggested by the finding that estrogen has antioxtdant properties and may preserve endothelmm-dependent vasodilation through the negative effect of superoxtde anIons that strongly inactivate NO.30 An alternative explanation may be represented by an Indirect estrogen effect mediated by lipid profile changes associated with sex hormone depravation or replacement Estrogen may directly improve lipid profile by decreasing plasma concentrattons of total and LDL cholesterol while mcreasmg high-density hpoprotem cholesterol, and mhibttmg oxtdation of the LDL fraction 6,8 Since both plasma lipid concentration and oxldatlve LDL status may directly Impair endothehal function, the posstbihty exists that an estrogen-mediated beneficial effect on these parameters could improve endothehum-dependent vasodilation. While the posstbihty of an estrogen effect on lipid plasma concentration is very unlikely m our experimental condittons, since the short periods of estrogen deprrvanon and replacement (1 and 3 months, respecttvely) do not induce sigmficant and chmcally relevant changes m the lipid profile (see Table l ), a possible reduction of LDL oxidatton cannot be ruled out by the present study A final mduect possibthty may be an estrogen-mediated effect on blood pressure values or glucose profile However, the present findings mdicatmg that these parameters did not significantly change throughout the study seem to be sufficient to exclude thts possibthty
The possibihty of a direct effect of sex hormones on endothehal function, as suggested by the impairment m vasodilating response after acute estrogen deprtvanon, 1s m keeping with the finding of mcreased endothelmm-dependent vasodrlatton after acute mfuston of estradiol m cynomolgus monkeys15 and m postmenopausal women. 18~0.21 Moreover, phystologtcal changes m endogenous estrogen during the menstrual cycle have recently been found to correlate positively with flowmediated vasodilation m the absence of lipid modifications, accounting for a direct action of estradtol m modulating endothehal function 31
Only few reports are available so far on the effect of chronic estrogen admmrstratron on the endothelmm of ovariectomized experimental animals and postmenopausal women undergoing replacement therapy An improvement m endothelmm-dependent vasodilatron after chrome estrogen administration has been found m atherosclerottc coronary arteries of ovartectomtzed monkeys 14 and in both the brachial artery16 and epmardtal coronary artertes17-I9 of postmenopausal women lh,19 In contrast, a recent report from Gilhgan et a132 failed to demonstrate an increased vasodrlating response to acetylcholine m postmenopausal women after 3 weeks of ERT by transdermal estradtol administered at an even higher dose as m our present investigation Although this study seems to be at variance with our results, both the different population characteristics, mainly age and time elapsed since menopause and the different length of ERT could account for the different findings Thus, mcreasmg age is associated with a decline m endothelium-dependent vasodilation,33J4 and this alteration is amplified in postmenopausal women 22 Therefore, tt 1s important to observe that we studied younger women shortly after ovariectomy-induced menopause, whtle Gilhgan et al evaluated an older study population, m most of whom menopause occurred years before Furthermore some evidence suggests that estrogen receptor levels within the vasculature may be closely related to the hormonal mrheu and may require a period of estrogen primmg.3Q6 Therefore, both the number of months or years since menopause and a more lasting exogenous estrogen exposure may be crucial m regulatmg receptor exposure to exogenous estrogen admmlstration. The difference m age and duration of menopause of the present study population compared with that evaluated by Gilligan et aI32 and the different period of treatment can thus be taken into account to explain the discrepancy m the results Endothelial dysfunction has been demonstrated in pathological conditions to be associated with an mcreased risk of CVD 33~~~37-40 The pivotal role of endothehum m the pathogenesis of vascular disease has been well documented by elucrdatmg its contribution to control of the interaction between blood and the vessel wall 41 The impaired endothehal responses associated with the ovarian estrogen loss may contribute to explaining the rise in incidence and severity of CVD m women who have early surgical menopause. Thus, there is evtdence suggesting that the demonstrated endothehal dysfunction at forearm level may reflect a more diffuse vascular alteration, as indicated by a report showing a close relationship between brachlal artery flow-mediated vasodilation and endothehal changes m coronary arteries.42
Our study, performed roughly 1 month after ovanectomy, allows the hypothesis of a direct effect of sex hormone depravation on vascular reactivity, occurrmg before lipid pattern changes, and provides further evidence of an estrogen action on endothehal function by the findmgs of a posmve effect of 3-month ERT.
In conclusion, these findings indicate that endothehumdependent vasodrlatron m women is influenced by hormonal status, which positively modulates endothehal function, suggesting that these mechanisms may be at least partially responsible for the protective role of estrogen m the development of CVD m women 
